Strikingly, the propeptide containing the naturally occurring pBDNF-Val66Met mutation, which is associated with memory impairment and predicts cognitive decline in AD patients [37–39], binds to SorCS2 with a greater affinity than pBDNF-WT [139]. The gene discussed is SORCS2; the disease is Alzheimer disease.